[HTML][HTML] Anti COVID-19 drugs: need for more clinical evidence and global action

Z Khan, Y Karataş, H Rahman - Advances in therapy, 2020 - Springer
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …

The coronavirus pandemic: what does the evidence show?

S Paudel, G Dangal, A Chalise, TR Bhandari, O Dangal - 2020 - elibrary.nhrc.gov.np
Abstract Coronavirus disease 2019 (COVID-19) is a newly emerged disease that has
become a global public health concern as it rapidly spread around the world. The etiologic …

[HTML][HTML] COVID-19 challenges and its therapeutics

SU Rehman, SU Rehman, HH Yoo - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …

Novel coronavirus disease (COVID‐19) update on epidemiology, pathogenicity, clinical course and treatments

M Boban - International Journal of Clinical Practice, 2021 - Wiley Online Library
During the December of 2019, a series of patients with pneumonia caused by novel
coronavirus; the severe acute respiratory syndrome (SARS) corona (COV‐2), that is, COVID …

[HTML][HTML] Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics)

S Hamid, MY Mir, GK Rohela - New microbes and new infections, 2020 - Elsevier
Abstract The coronavirus disease (COVID-19) is highly pathogenic viral infection caused by
SARS-CoV-2. Currently, COVID-19 has caused global health concern. It is assumed that …

[HTML][HTML] Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …

[HTML][HTML] Preventive and treatment strategies of COVID-19: from community to clinical trials

KK Sahu, R Kumar - Journal of family medicine and primary care, 2020 - journals.lww.com
The latest threat to global health is the form of the ongoing Coronavirus Disease 2019
(COVID-19) pandemic. This new coronavirus (SARS-COV-2) started as a local outbreak in …

Review on the coronavirus disease (COVID‐19) pandemic: its outbreak and current status

D Almaghaslah, G Kandasamy… - … journal of clinical …, 2020 - Wiley Online Library
Abstract Background In late December 2019 and on 1st January 2020, the coronavirus
(COVID‐19) infecting humans was first identified in Wuhan, Hubei Province, China. Later …

[HTML][HTML] An overview on COVID-19: reality and expectation

MA Hamed - Bulletin of the National Research Centre, 2020 - Springer
Recently, severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), commonly
known as coronavirus disease-2019 (COVID-19) has rapidly spread across China and …